|
FTSJD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.39805961147022E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.21790372126429E-11 |
| Normal-vs-Stage2 |
1.19980000001796E-06 |
| Normal-vs-Stage3 |
7.99709964915962E-10 |
| Normal-vs-Stage4 |
2.74980005432468E-09 |
| Stage1-vs-Stage2 |
8.185200E-01 |
| Stage1-vs-Stage3 |
2.812200E-01 |
| Stage1-vs-Stage4 |
3.362000E-01 |
| Stage2-vs-Stage3 |
6.380000E-01 |
| Stage2-vs-Stage4 |
6.026600E-01 |
| Stage3-vs-Stage4 |
9.269200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.45348186211913E-12 |
| Normal-vs-AfricanAmerican |
1.523140E-03 |
| Normal-vs-Asian |
2.11869999999781E-06 |
| Caucasian-vs-AfricanAmerican |
1.776640E-01 |
| Caucasian-vs-Asian |
4.869200E-01 |
| AfricanAmerican-vs-Asian |
4.839200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84560000615619E-09 |
| Normal-vs-Female |
4.55169235635822E-12 |
| Male-vs-Female |
9.318800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32040045563997E-10 |
| Normal-vs-Age(41-60Yrs) |
1.72329994718723E-09 |
| Normal-vs-Age(61-80Yrs) |
1.36249900251073E-11 |
| Normal-vs-Age(81-100Yrs) |
1.526800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.747600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.259600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.683400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.544200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.152400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.782600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.298500E-03 |
| Classical-VS-Follicular |
8.994500E-04 |
| Classical-VS-Other |
6.718300E-02 |
| Classical-VS-Normal |
1.75680003877687E-09 |
| Tall-VS-Follicular |
6.387800E-01 |
| Tall-VS-Other |
6.610000E-01 |
| Tall-VS-Normal |
1.28999999571278E-09 |
| Follicular-VS-Other |
5.640400E-01 |
| Follicular-VS-Normal |
8.44769809660306E-11 |
| Other-VS-Normal |
1.824380E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61400004472512E-09 |
| Normal-vs-N1 |
8.08929589979357E-11 |
| N0-vs-N1 |
9.434400E-02 |
|
|
